ClearPoint Neuro (CLPT) Enterprise Value (2011 - 2026)
ClearPoint Neuro (CLPT) reported Enterprise Value of -$35.6 million for Q1 2026, down 187.34% on a YoY basis from $40.8 million in Q1 2025, and up 22.49% sequentially from -$45.9 million in Q4 2025.
ClearPoint Neuro (CLPT) Enterprise Value (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 16 years of Enterprise Value data on file, last reported at -$35.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 187.34% year-over-year to -$35.6 million; the trailing twelve-month figure through Mar 2026 stood at -$35.6 million (down 187.34% YoY), and the FY2025 full-year result was -$45.9 million, down 128.47% from the prior year.
- Enterprise Value advanced to -$35.6 million in Q1 2026, from -$45.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$12.4 million in Q1 2025 to a low of -$49.7 million in Q1 2022.
- A 5-year average of -$33.0 million and a median of -$35.4 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 64.96% in 2025 and plunged 187.34% in 2026, its largest moves.
- Tracing CLPT's Enterprise Value over 5 years: stood at -$37.5 million in 2022, then surged by 38.42% to -$23.1 million in 2023, then increased by 12.99% to -$20.1 million in 2024, then slumped by 128.47% to -$45.9 million in 2025, then climbed by 22.49% to -$35.6 million in 2026.
- Business Quant data shows CLPT's Enterprise Value at -$35.6 million in Q1 2026, -$45.9 million in Q4 2025, and -$38.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -35.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.59 Mn |
| Dec 31, 2025 | -45.92 Mn |
| Sep 30, 2025 | -38.20 Mn |
| Jun 30, 2025 | -41.50 Mn |
| Mar 31, 2025 | -12.39 Mn |
| Dec 31, 2024 | -20.10 Mn |
| Sep 30, 2024 | -21.57 Mn |
| Jun 30, 2024 | -32.85 Mn |
| Mar 31, 2024 | -35.35 Mn |
| Dec 31, 2023 | -23.10 Mn |
| Sep 30, 2023 | -24.34 Mn |
| Jun 30, 2023 | -26.50 Mn |
| Mar 31, 2023 | -31.69 Mn |
| Dec 31, 2022 | -37.52 Mn |
| Sep 30, 2022 | -40.46 Mn |
| Jun 30, 2022 | -45.10 Mn |
| Mar 31, 2022 | -49.66 Mn |
| Dec 31, 2021 | -54.10 Mn |
| Sep 30, 2021 | -57.65 Mn |
| Jun 30, 2021 | -61.52 Mn |